Sternberg CN - Search Results

1

The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.

Sonpavde G, Attard G, Bellmunt J, Mason MD, Malavaud B, Tombal B, Sternberg CN. Sonpavde G, et al. Among authors: sternberg cn. Eur Urol. 2011 Aug;60(2):270-8. doi: 10.1016/j.eururo.2011.04.032. Epub 2011 Apr 29. Eur Urol. 2011. PMID: 21550166 Review.

2

The medical management of prostate cancer: a multidisciplinary team approach.

Sternberg CN, Krainer M, Oh WK, Bracarda S, Bellmunt J, Ozen H, Zlotta A, Beer TM, Oudard S, Rauchenwald M, Skoneczna I, Borner MM, Fitzpatrick JM. Sternberg CN, et al. BJU Int. 2007 Jan;99(1):22-7. doi: 10.1111/j.1464-410X.2006.06477.x. Epub 2006 Sep 6. BJU Int. 2007. PMID: 16956362 Review. No abstract available.

3

Current indications for chemotherapy in prostate cancer patients.

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. Eur Urol. 2007 Jan;51(1):17-26. doi: 10.1016/j.eururo.2006.08.013. Epub 2006 Aug 22. Eur Urol. 2007. PMID: 17007996 Review.

4

Prostate cancer chemotherapy. Interview by Christine McKillop.

Sternberg CN. Sternberg CN. Eur Urol. 2007 Apr;51(4):1136-8. doi: 10.1016/j.eururo.2007.01.037. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17250951 No abstract available.

5

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS. Sternberg CN, et al. Urology. 2007 Jan;69(1 Suppl):62-79. doi: 10.1016/j.urology.2006.10.041. Urology. 2007. PMID: 17280909 Review.

6

Novel agents for muscle-invasive and advanced urothelial cancer.

Sonpavde G, Ross R, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Lerner SP, Sternberg CN. Sonpavde G, et al. Among authors: sternberg cn. BJU Int. 2008 Apr;101(8):937-43. doi: 10.1111/j.1464-410X.2007.07326.x. Epub 2007 Nov 13. BJU Int. 2008. PMID: 18005203 Review.

7

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma.

Sonpavde G, Hutson TE, Sternberg CN. Sonpavde G, et al. Among authors: sternberg cn. Expert Opin Investig Drugs. 2008 Feb;17(2):253-61. doi: 10.1517/13543784.17.2.253. Expert Opin Investig Drugs. 2008. PMID: 18230058 Review.

8

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks.

Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. Isbarn H, et al. Among authors: sternberg cn. Eur Urol. 2009 Jan;55(1):62-75. doi: 10.1016/j.eururo.2008.10.008. Epub 2008 Oct 14. Eur Urol. 2009. PMID: 18945543 Free PMC article. Review.

9

Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.

Sonpavde G, Sternberg CN. Sonpavde G, et al. Among authors: sternberg cn. BJU Int. 2008 Nov;102(9 Pt B):1354-60. doi: 10.1111/j.1464-410X.2008.07982.x. BJU Int. 2008. PMID: 19035904 Review.

10

Metastatic renal cell carcinoma: recent advances in the targeted therapy era.

Di Lorenzo G, Autorino R, Sternberg CN. Di Lorenzo G, et al. Among authors: sternberg cn. Eur Urol. 2009 Dec;56(6):959-71. doi: 10.1016/j.eururo.2009.09.002. Epub 2009 Sep 8. Eur Urol. 2009. PMID: 19748725 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters